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Abstract
Background: Insulin-like growth factor-2 (IGF-2) is a polypeptide growth factor and
one of the first genes expressed prior to the implantation of the embryo, with its
highest expression in the placental cells. Its activity strongly depends on the genomic
imprinting, and the result of the loss of genetic imprinting is the termination of the early
stages of embryonic development, which can lead to recurrent spontaneous abortion.
Objective: This cross-sectional study aimed to investigate the role of 820A/G variant of
the IGF-2 gene and the probability to recurrent spontaneous abortion (RSA) in southern
Iran.
Materials and Methods: In this study, 50 aborted fetuses tissue for the study group
and blood samples umbilical-cord from newborns as control group (n = 50) were
collected from Shiraz-Iran (2017). The genotyping of the target point in the IGF-2 gene
was performed by Real-time Polymerase Chain Reaction and analyzed through high-
resolution melting (HRM) curve.
Results: Based on the collected data (AA genotype = reference), allele “A” frequency in
aborted fetus was 51% and control 68% as well as allele G 49% and 32%, respectively.
Moreover, 27 aborted embryos (54%) were heterozygous (A/G) (OR = 3.274, 95%
CI = 1.015-10.561, p = 0.04), while 18 cases (36%) in control sample showed
heterozygosity. Considering the phenotypic status, the G allele had a dominant effect
on the incidence of RSA (p = 0.008, OR = 3.167).
Conclusion: Based on the present study, the risk of abortion due to loss of
heterozygosity or quantitative decline of the IGF-2 is about three-fold in the southern
Iran.
Key words: Variant, IGF-2, Spontaneous abortion, Genomic imprinting, Gene
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1. Introduction
Recurrent spontaneous abortion (RSA) is
referred to three or more times of spontaneous
fetal death prior to the 20th wk of pregnancy (1,
2). Several genetic and non-genetic factors may
induce RSA, such as polycystic ovarian syndrome
and quantitative and structural chromosomal
abnormalities. It is generally accepted that the
most common factors in the first trimester abortion
is caused by chromosomal abnormalities (3, 4). It is
believed that etiological causes of RSA usually are
unclear in 30-50% of cases (5). As a result, some
idiopathic abortions may be caused by genetic
variant that changes in specific genes. These
variations, so-called imprinted genes, could affect
maternal or paternal genome activity and lead
to RSA (6). Genomic imprinting is an epigenetic
modification that affects gene expression in
paternally or maternally originated genes. This
process contradicts Mendelian inheritance. These
genes do not have biallelic expression and only
one allele is expressed in the genomic imprinting
process, depending on the allelic origin of the
parents (7).
In human, around 60 genes identified that
is affected by the phenomenon of genetic
imprinting (8, 9). Their expressions are critical
during developmental fetal times. Many of them
are regulatory genes involved in the growth and
development of the fetus and are functionally
hemizygous pattern. Therefore, alteration of
effective copy number can cause developmental
disorders.
Among these genes, the Insulin-like growth
factor-2 (IGF-2) gene at the position 11p15.5 is
paternally expressed in fetus (10). The position in
chromosome includes an imprinting region that
contains the IGF2 gene, which is consequently
linked to the H19 gene. The IGF2/H19 expression
is regulated by two imprinting control regions (ICR1
and ICR2). The ICR1 is a differentially methylated
region at the upstream H19 promoter (11, 12). On
the maternal allele, the CTCF protein, a zinc
finger protein, binds to differentially methylated
region (13, 14) and subsequently un-methylated
maternal allele prevents IGF-2 interaction with an
H19 enhancer at the downstream and inhibits IGF-2
expression. Methylation of this region on a paternal
allele changes the expression of gene profile and
favors IGF-2 expression (15). IGF-2 gene-encoded
protein is involved in prenatal growth and is highly
active during embryonic development. The activity
of the IGF-2 gene depends on the copy that is
inherited from the father (16). IGF-2 gene regulates
the growth rate of the placenta and the embryo
through angiogenesis (17-20), nutrient transfer (21),
and inhibition of apoptosis (22), and its dysfunction
can lead to miscarriage (23, 24). The IGF-2 gene
has single nucleotide polymorphism in its different
regions that affects its expression quantities and
function. One of such known single nucleotide
polymorphism is 820A/G variant (25). This variant
in the father reduces gene expression and leads to
abortion (26). The diagnosis of paternal 820 A/G-
genotypes of the IGF-2 gene helps to predict the
prospect of fetal loss due to gene imprinting.
This study was intended to inspect the
frequency and potential effects of alleles in
women with recurrent abortions to open a way to
prevent this public burden.
2. Materials and Methods
2.1. Samples
During a period of six months (May-October
2017), for a cross-sectional study, 232 dead fetuses
were collected from the labor wards of Hafez
and Zeinabiea Hospitals, Shiraz-Iran. Ninety one
of collected fetuses were from mothers who had
experienced at least two or more consecutive
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miscarriages. Additionally, 22 cases were excluded
due to abnormal sonography or maternal abnormal
lab data. All fetuses with abnormal karyotype
or Noninvasive prenatal testing (NIPT) (19 cases)
were excluded from the study as well. Finally,
50 fetal tissue samples with normal karyotype
were enrolled and included for molecular analysis.
A match group was randomly selected from 50
mothers who had at least one delivery after 37 wk
gestation as the control group and blood samples
were taken from the neonates. Cases with non-
spontaneous abortions as well as known disorders
or anatomical abnormalities were excluded from
the study. Demographic data of dead fetuses and
controls presented in table I.
About 1 cm of aborted fetal tissue was stored
at -20°C and used for DNA extraction. Samples
were collected through questionnaire requiring
information with spouse at the time of admission.
2.2. Genetic analysis
Genomic DNA was extracted using PureLink
genomic DNA kit (Life Technologies, CA, USA)
according to the manufacturer’s instruction. Quality
and quantity of DNA were investigated using 0.8%
agarose gel (Sigma-Aldrich, USA) electrophoresis
and Nanodrop spectrophotometer device (BioTek
Company,Germany). For the 820 A/G genotyping,
Real-time Polymerase Chain Reaction was done
with LC-Green (Idaho Technology, Salt Lake City,
Utah, USA), and a high-resolution melting (HRM)
analysis method following PCR amplification
(Qiagen company, USA) was performed.
All samples were run along with positive and
normal controls that were originally approved by
Sanger sequencing method. Data were analyzed
and genotyped using the HRM software.
2.3. Real-time PCR reactions and
melting analysis
A 10 µL reaction mixture with the Master Mix
(2×) (Promega, Madison, WI, USA), LC Green Plus
(10×) (Idaho Technology, Salt Lake City, Utah, USA)
prepared. Final concentration of primers mixture
and DNA was 10 µM and 200 pg/µL, respectively.
The sequence of primers for IGF-2 (820A/G)
design was done by online Primer 3 software. The
sequence of designed primers are: (5’-CTT GAG
TCC CTG AAC CAG CA-3’) and (5’-TTC GGA TGG
CCA GTT TAC CC-3’). The reaction PCR conditions
were: initial cycle 95°C for 90 sec, followed by
30 cycles of 95°C for 25 sec, and annealing
and extension temperature for 30 sec with final
extension of 72°C for 2 min. Melting analysis at the
range of 65-95°C with an increment 0.1°C for 10
s was performed. Bio-Rad Precision Melt Analysis
Software, version 1.2 (Bio-Rad Laboratories Inc.,
USA) was used for data analysis (Figure 1).
Table I. Demographic data of cases and controls
Characteristic Aborted fetus (n = 50) Control group (n = 50) P-value*
Range of mother age (yr) 26-39 25-38
Average of mother age (yr)* 32.77 ± 4.23 32.59 ± 3.89 0.942
Average of fetus age* 12.05 ± 3.2 -
Average age of infants born* - 38.54 ± 1.16
Range number of abortions 3-4 -
Average number of abortions* 3.05 ± 1.64 -
Data presented as Mean ± SD. *P-value by Student t test
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Figure 1. HRM analysis results to determine the genotype of the positional products polymorphisms 820 G/A in the IGF-2 gene.
The Real-time device shows diagram based on fluorescence variations relative to temperature variations. In this chart, each of
the peaks represents the melting of a product PCR and, accordingly, determines the genotype.
2.4. Ethical consideration
The research was performed with the approval
Ethics Committee of Islamic Azad University
of Dehaghan Branch, Dehaghan, Iran (Code:
IR.IAU.DEHAGHAN.REC.1397.001). Written
informed consent was obtained from all candidates
before taking samples.
2.5. Statistical analysis
The statistical analysis was performed using the
SPSS software (Statistical Package for the Social
Sciences, version 22; SPSS, Chicago, IL, USA)
and Chi-square (𝜒2) test by analysis of logistic
regression; p < 0.05 was considered as the level of
significance and A/G distribution was in agreement
with the Hardy-Weinberg equilibrium (HWE). Odds
ratio (OR) and p-value with 95% confidence interval
(CI) were considered to estimate the risk RSA for
820A/G variant in the IGF-2 gene in the study group
with RSA and control groups. Student’s t test was
used to compare the mean age of the mothers
between the two groups and Fisher’s exact test for
p-value.
3. Results
In present study, there was no significant
difference between the mean age of mothers,
the mothers of the control group with age 32.59
± 3.89 yr compared to the mothers of aborted
fetuses with age 32.77 ± 4.23 (p = 0.942) (Table
I). The allelic and genotypic frequency of 820
A/G in the IGF-2 gene was studied in case and
control groups. The ancestral allele A is considered
as the reference. Based on the results of the
statistical analysis revealed, the G allele is effective
in recurrent abortions (p = 0.015). Considering
the AA-genotype, as reference and analysis of
other genotypes relative to this position obtained
a statistically significant relationship (p = 0.04 for
AG- genotype and p = 0.935 for GG-genotype).
The AG genotype is effective in the incidence of
recurrent miscarriage; the calculated OR showed
that A/G genotype of the IGF-2 gene at 820 locus
increased the incidence of spontaneous abortion
more than three-fold. Considering the phenotypic
status to the advantage of allele dominance in
G, a significant relationship was obtained. The
statistical analysis results are presented in Table
II.
Page 750 https://doi.org/10.18502/ijrm.v13i9.7669
International Journal of Reproductive BioMedicine IGF-2 gene variant and recurrent abortion
Table II. The distribution of genotypes and alleles of 820A/G in the IGF-2 gene in control and aborted fetus s with RSA
Genotype/Allele Control group Aborted fetus Odds ratio CI%95 P-value*
AA 25 (50) 12 (24) _ Reference -
AG 18 (36) 27 (54) 3.274 1.015-10.561 0.04
GG 7 (14) 11 (22) 1.048 0.342-3.210 0.935
A 68 (68) 51 (51) - Reference -
G 32 (32) 49 (49) 2.042 3.627-1.149 0.015
GG+AG (G+) 25 (50) 38 (76) 3.167 1.349-7.435 0.008
AA+AG (A+) 43 (86) 39 (78) 0.577 0.204-1.636 0.301
Data presented as n (%).*P-value by Fisher’s exact test
4. Discussion
The cause and mechanism underlying the traits
and conditions that induce recurrent abortion
is an important challenge for current genetics.
Now, it is well-accepted that some human traits
depend on the parent from whom the gene
responsible for the trait is inherited. Obviously,
the zygotes that were generated by maternally or
paternally derived chromosomes could not survive
to term. Development failure results from the entire
chromosome complement inherited from only
one parent. Comparison of gross morphologic
complementarity of the phenotypes resulting from
paternal sets of chromosomes versus maternal
sets suggests that paternal genetic contribution
is important for placental development, while
maternal contribution is essential for proper
embryo development (27).
Recently, frequent reports indications a
connection between pregnancy complications
such as restricted embryonic growth and RSA and
the role of the IGF-2 gene. IGF-2 is known as a
strong mitogen and is part of a cluster of imprinting
genes on human chromosomes. Most imprinting
genes are associated with embryo growth. The
820 A/G variation is a functional polymorphism and
alter the primary sequence of encoded protein.
This variation at the genomic level strongly affects
the transcription level and alter IGF-2 expression
status. Thus, mRNA transcription of the IGF-2
gene in the presence of this polymorphism will
change quantatively. The G allele of the IGF-2
gene and plasma levels of IGF-2 protein as well as
IGF-2mRNA shows positive correlation. Therefore,
heterozygote A/G at position 820 of this gene
could results in loss of genomic imprinting manner
in IGF-2 expression (25, 26, 28, 29).
The expression of the paternal allele is due to
the changes in the epigenetic, including changes
in the DNA structure such as DNA methylation.
Imprinting genes or gene expression regulation is
conducted via chromatin fiber change. The loss
of the genetic imprinting (LOI) can result in a
loss of the allele and imbalance (loss of function
or increase in it) in a rate of the gene product
and possibly also lead to the phenotypic outcome
(30). Thus, the LOI leads to the loss of normal
growth and development of the fetus. In order to
clarify IGF-2 gene significance in the growth and
development of pre-natal, Lighten and colleagues
analyzed IGF genes and their receptors (IGF-1-IGF-
2) expression in chorionic cells. Transcripts were
evident that both genes and their receptors exist in
human zygote cells before implantation. Although,
according to the ligands, only transcripts of the IGF-
2 ligand was detected. Based on their results, while
before implantation, the parental allele function
is blocked, genomic imprinting participated at the
period of 8-cell embryo (31, 32). Therefore, it can
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be assumed that in RSA, the function of the genetic
imprinting mechanism is not started, which results
at the end of the growth of the organism (25).
Ostojic and co-worker have reviewed the
genetic background of idiopathic RSA and
the contribution of genetic changes to IGF-2
and H19 imprinting genes. This case-sectional
study determined the relationship between
IGF-2 820A/G and H19 HhaI gene variant RSA
susceptibility. There was a significant difference in
the frequency of IGF-2 820A/G in men with RSA
compared to healthy men (p < 0.0001). There was
no difference in the distribution of this genotypic
women’s groups. The presence of IGF-2 the 820
variant among the husbands of these women in
RSA couples can affect the expression of IGF-2
in the placenta and embryo and represents a risk
factor for RSA sensitivity (26). In addition, a study of
107 placental tissue samples fromUkraine reported
that aborted embryos at 10-15 wk of pregnancy,
carrier fetus with 820 A/G genotype, has seven
times more chance to develop RSA as compared
to the AA genotype (25). This study is also in line
with the findings of Koukoura and colleagues from
Greece who studied 31 placentas with fetal growth
restriction (FGR) and found decline in IGF2 mRNA
levels and LOI among the abnormal placentas. The
epigenetic mechanism that regulates the genetic
imprinting of the IGF-2 gene leads to FGR and
induce significantly the reduction at the level of
IGF-2 mRNA (15).
Although our study shows that the chance
of RSA due to paternal G allele is increased
about three times, this finding is still meaningfully
lower than expected in comparison to the other
study (Table III). The high rate of consanguinity
marriage may introduce other possible genetic
factors contributing to the development of RSA.
Table III. A Comparative view of this study (Fars-Iran) with Croatia and Ukraine
IGF-2 Genotype Control Patient OR P-value
A/G genotype
Iran 18 (36), n = 50 27 (54), n = 50 3.274 0.04
Croatia 28 (24.8), n = 113 54 (47.8), n = 113 3.274 < 0.0001
Ukraine 9 (0.225), n = 40 74 (0.692), n = 107 7.7239 < 0.01
G/G genotype
Iran 7 (14), n = 50 11 (22), n = 50 1.048 0.935
Croatia 22 (19.5), n = 113 44 (38.9), n = 113 - < 0.0001
Ukraine 27 (0.675), n = 40 22 (0.206), n = 107 - < 0.0001
Data presented as n (%); OR and P-value by Fisher’s exact test
5. Conclusion
This study indicates that carriers of GG or A/G
genotype are three times more likely to have
recurrent abortion in our population.
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